|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dimethylaminopropionitrile | CAS 1738-25-6 | ||
| (CH3)2NCH2CH2CN | RTECS UG1575000 | ||
|
Synonyms & Trade Names 3-(Dimethylamino)propionitrile; N,N-Dimethylamino-3-propionitrile [Note: A component (95%) of NIAX® Catalyst ESN, along with bis(2-(dimethylamino)ethyl) ether (5%).] |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: See Appendix C (NIAX® Catalyst ESN) | ||
| OSHA PEL: See Appendix C (NIAX® Catalyst ESN) | |||
| IDLH N.D. | Conversion | ||
|
Physical Description Colorless liquid. |
|||
|
MW: 98.2 |
BP: 342°F |
FRZ: -48°F |
Sol: Miscible |
|
VP(135°F): 10 mmHg |
IP: ? |
|
Sp.Gr(86°F): 0.86 |
|
Fl.P: 147°F |
UEL: ? |
LEL: ? |
|
| Class IIIA Combustible Liquid: Fl.P. at or above 140�F and below 200�F. | |||
|
Incompatibilities & Reactivities Oxidizers [Note: Emits toxic oxides of nitrogen and cyanide fumes when heated to decomposition.] |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin; urinary disturbance; neurological disorders; pins & needles in hands & feet; muscle weakness, lassitude (weakness, exhaustion), nausea, vomiting; decreased nerve conduction in lower legs | |
|
Target Organs
Eyes, skin, central nervous system, urinary tract |
|
| See also: INTRODUCTION |